2,3,4,7-TETRA-O-BENZYL-2-EPI-5-EPI-[6-(2)H(2)]-VALIOLONE
Compound with spectra: 2 NMR
![2,3,4,7-TETRA-O-BENZYL-2-EPI-5-EPI-[6-(2)H(2)]-VALIOLONE](/api/compound/HkwLs2B8Tdy.png?ph=true&h=300&w=458 "2,3,4,7-TETRA-O-BENZYL-2-EPI-5-EPI-[6-(2)H(2)]-VALIOLONE")
| SpectraBase Compound ID | HkwLs2B8Tdy |
|---|---|
| InChI | InChI=1S/C35H36O6/c36-31-21-35(37,26-38-22-27-13-5-1-6-14-27)34(41-25-30-19-11-4-12-20-30)33(40-24-29-17-9-3-10-18-29)32(31)39-23-28-15-7-2-8-16-28/h1-20,32-34,37H,21-26H2/t32-,33-,34+,35?/m1/s1 |
| InChIKey | JWXHKWBUBUUEFP-ANDILNNCSA-N |
| Mol Weight | 552.7 g/mol |
| Molecular Formula | C35H36O6 |
| Exact Mass | 552.251189 g/mol |
| Enantiomer InChIKey | JWXHKWBUBUUEFP-XUXZVKKGSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 2,3,4,7-TETRA-O-BENZYL-2-EPI-[6-(2)H(2)]-VALIOLONE
1,3,4,5,6-PENTA-O-BENZYL-2-C-TRICHLOROMETHYL-MYO-INOSITOL
(4S,5S,6S)-4-[(1E)-1,5-dimethyl-1,4-hexadienyl]-5,6-bis[(4-methoxybenzyl)oxy]-1-oxaspiro[2.5]octane
(2S,4aS,6R,7R,8S,8aS)-7,8-bis(benzyloxy)-6-(benzyloxymethyl)-2-(but-3-enyl)hexahydropyrano[3,2-b]pyran-3(2H)-one
1,6-ANHYDRO-TRI-O-BENZYL-5-HYDROXY-BETA-L-IDOPYRANOSIDE
3,4,5-TRI-O-BENZYL-7-DEOXY-7-FLUORO-D-GLYCERO-ALPHA-D-LYXO-HEPT-2-ULOPYRANOSIDE
1,3-Dioxolo[4,5-c]pyran, tetrahydro-, 7-(2-acetoxyethyl)-7-hydroxy-2,2-dimethyl-4-(3-methoxycarbonyl-2-methylallyl)-
(2R,3R,5R,6R)-2,6-DIBENZYLOXY-8-BROMO-5-(TERT.-BUTYLDIMETHYLSILOXY)-3-(PARA-METHOXYBENZYLOXY)-4,4-DIMETHYL-7-OXOOCTANAL
(2R,3S,4S,5R)-3,4,5-TRIS-(BENZYLOXY)-2-((BENZYLOXY)-METHYL)-6-ETHOXY-2,3,4,5-TETRAHYDROPYRIDINE
| Title | Journal or Book | Year |
|---|---|---|
| Biosynthetic Studies on the α-Glucosidase Inhibitor Acarbose in Actinoplanes sp.: 2-epi-5-epi-Valiolone Is the Direct Precursor of the Valienamine Moiety | Journal of the American Chemical Society | 1999 |